Targeting myeloid cells to improve cancer immune therapy

Tumor immunosuppression remains a major barrier to effective cancer immunotherapy and is often driven by the immunoregulatory activities of innate immune cells, such as myeloid cells within the tumor microenvironment (TME). Myeloid populations—including tumor-associated macrophages (TAMs), dendritic...

Cijeli opis

Bibliografski detalji

Glavni autori:	Hui Chen, Zihan Xu, Judith Varner
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-07-01
Serija:	Frontiers in Immunology
Teme:	myeloid cell tumor associated macrophage (TAM) PI3Kgamma TREM2 CSF1R (colony stimulating factor 1 receptor) Axl
Online pristup:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1623436/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!